T1	Participants 16 53	advanced gastric carcinoma (stage IV)
T2	Participants 105 166	Forty-six patients with advanced gastric carcinoma (Stage IV)
T3	Participants 312 389	Treatment groups were well balanced with respect to known prognostic factors.
T4	Participants 390 511	Thirty-three patients had measurable disease and thirteen had only microscopic residual disease in the resection margins.
